179 related articles for article (PubMed ID: 37536407)
21. Lectins in human pathogenic fungi.
Gallegos B; Martínez R; Pérez L; Del Socorro Pina M; Perez E; Hernández P
Rev Iberoam Micol; 2014; 31(1):72-5. PubMed ID: 24270074
[TBL] [Abstract][Full Text] [Related]
22. Aiming for the Insulin-like Growth Factor-1 system in breast cancer therapeutics.
Christopoulos PF; Corthay A; Koutsilieris M
Cancer Treat Rev; 2018 Feb; 63():79-95. PubMed ID: 29253837
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer molecular subtypes--modern therapeutic concepts for targeted therapy of a heterogeneous entity.
Liedtke C; Kiesel L
Maturitas; 2012 Dec; 73(4):288-94. PubMed ID: 23020990
[TBL] [Abstract][Full Text] [Related]
24. Progression and treatment of HER2-positive breast cancer.
Davoli A; Hocevar BA; Brown TL
Cancer Chemother Pharmacol; 2010 Mar; 65(4):611-23. PubMed ID: 20087739
[TBL] [Abstract][Full Text] [Related]
25. Breast Cancer: Current Molecular Therapeutic Targets and New Players.
Nagini S
Anticancer Agents Med Chem; 2017; 17(2):152-163. PubMed ID: 27137076
[TBL] [Abstract][Full Text] [Related]
26. Tracking progesterone receptor-mediated actions in breast cancer.
Knutson TP; Lange CA
Pharmacol Ther; 2014 Apr; 142(1):114-25. PubMed ID: 24291072
[TBL] [Abstract][Full Text] [Related]
27. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
28. Mushroom lectins in biomedical research and development.
Singh RS; Walia AK; Kennedy JF
Int J Biol Macromol; 2020 May; 151():1340-1350. PubMed ID: 31751693
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant.
Carcel-Trullols J; Stanley JS; Saha R; Shaaf S; Bendre MS; Monzavi-Karbassi B; Suva LJ; Kieber-Emmons T
Int J Oncol; 2006 May; 28(5):1173-83. PubMed ID: 16596233
[TBL] [Abstract][Full Text] [Related]
30. Leveraging Antiprogestins in the Treatment of Metastatic Breast Cancer.
Kamaraju S; Fowler AM; Weil E; Wisinski KB; Truong TH; Lehr M; Chaudhary LN; Cheng YC; Chitambar CR; Rui H; Yee D; Lange C
Endocrinology; 2021 Aug; 162(8):. PubMed ID: 33735382
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in the use of legume lectins for the diagnosis and treatment of breast cancer.
Cavada BS; Oliveira MV; Osterne VJS; Pinto-Junior VR; Martins FWV; Correia-Neto C; Pinheiro RF; Leal RB; Nascimento KS
Biochimie; 2023 May; 208():100-116. PubMed ID: 36586566
[TBL] [Abstract][Full Text] [Related]
32. Bauhinia forficata lectin (BfL) induces cell death and inhibits integrin-mediated adhesion on MCF7 human breast cancer cells.
Silva MC; de Paula CA; Ferreira JG; Paredes-Gamero EJ; Vaz AM; Sampaio MU; Correia MT; Oliva ML
Biochim Biophys Acta; 2014 Jul; 1840(7):2262-71. PubMed ID: 24641823
[TBL] [Abstract][Full Text] [Related]
33. Advances in molecular mechanisms of drugs affecting abnormal glycosylation and metastasis of breast cancer.
Liu H; Ma L; Lin J; Cao B; Qu D; Luo C; Huang W; Han L; Xu H; Wu Z; Xu R; Zhang D
Pharmacol Res; 2020 May; 155():104738. PubMed ID: 32151681
[TBL] [Abstract][Full Text] [Related]
34. Recent advances toward the development of inhibitors to attenuate tumor metastasis via the interruption of lectin-ligand interactions.
Rachel H; Chang-Chun L
Adv Carbohydr Chem Biochem; 2013; 69():125-207. PubMed ID: 24274369
[TBL] [Abstract][Full Text] [Related]
35. Lectins as antimicrobial agents.
Breitenbach Barroso Coelho LC; Marcelino Dos Santos Silva P; Felix de Oliveira W; de Moura MC; Viana Pontual E; Soares Gomes F; Guedes Paiva PM; Napoleão TH; Dos Santos Correia MT
J Appl Microbiol; 2018 Nov; 125(5):1238-1252. PubMed ID: 30053345
[TBL] [Abstract][Full Text] [Related]
36. BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib.
Godinho MF; Wulfkuhle JD; Look MP; Sieuwerts AM; Sleijfer S; Foekens JA; Petricoin EF; Dorssers LC; van Agthoven T
Br J Cancer; 2012 Sep; 107(6):947-55. PubMed ID: 22892392
[TBL] [Abstract][Full Text] [Related]
37. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
BeLow M; Osipo C
Cells; 2020 Sep; 9(10):. PubMed ID: 33003540
[TBL] [Abstract][Full Text] [Related]
38. Plant lectins: targeting programmed cell death pathways as antitumor agents.
Fu LL; Zhou CC; Yao S; Yu JY; Liu B; Bao JK
Int J Biochem Cell Biol; 2011 Oct; 43(10):1442-9. PubMed ID: 21798364
[TBL] [Abstract][Full Text] [Related]
39. Are matrix-immobilized neoglycoproteins, plant and human lectins and carbohydrate--binding antibodies from human serum mediators of adhesion in vitro for carcinoma and lymphosarcoma cells?
Wawotzny R; André S; Dong X; Joshi SS; Gabius HJ
Anticancer Res; 1995; 15(1):169-74. PubMed ID: 7733629
[TBL] [Abstract][Full Text] [Related]
40. Lectins applied to diagnosis and treatment of prostate cancer and benign hyperplasia: A review.
Cavada BS; Oliveira MV; Osterne VJS; Pinto-Junior VR; Correia-Neto C; Nascimento KS
Int J Biol Macromol; 2021 Nov; 190():543-553. PubMed ID: 34508719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
